Acute encephalopathy with refractory status epilepticus: Bilateral mesial temporal and claustral lesions, associated with a peripheral marker of oxidative DNA damage

Journal of the Neurological Sciences

Volumn 250, Issue 1-2, 2006, Pages 159-161

  Shiihara, Takashi ^a   Kato, Mitsuhiro ^a   Ichiyama, Takashi ^b   Takahashi, Yukitoshi ^c   Tanuma, Naoyuki ^d   Miyata, Rie ^e   Hayasaka, Kiyoshi ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SHIZUOKA INSTITUTE OF EPILEPSY AND NEUROLOGICAL DISORDERS   (Japan)

^d Department of Pediatrics   (Japan)

^e Tokyo Kita Shakai Hoken Hospital   (Japan)

Author keywords

8 hydroxydeoxyguanosine; Acute encephalopathy; Claustrum; Oxidative stress; Status epilepticus; Theophylline

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANESTHETIC AGENT; DNA; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; PROPOFOL; THEOPHYLLINE; THIAMYLAL; THIOPENTAL; VALPROIC ACID;

ACUTE BRAIN DISEASE; ARTICLE; ASTHMA; ATELECTASIS; BRAIN DAMAGE; BRAIN REGION; CASE REPORT; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLAUSTRUM; DEHYDRATION; DNA DAMAGE; DRUG MEGADOSE; EPILEPTIC STATE; FEMALE; HUMAN; HYPOTENSION; KIDNEY FAILURE; LEUKOPENIA; LIVER FAILURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PRIORITY JOURNAL; TEMPORAL LOBE; THROMBOPHLEBITIS; TONIC SEIZURE; TREATMENT FAILURE;

ACUTE DISEASE; ANTICONVULSANTS; ATROPHY; BASAL GANGLIA; BIOLOGICAL MARKERS; BRAIN; BRAIN DISEASES, METABOLIC; BRONCHODILATOR AGENTS; CHILD; COMORBIDITY; DEOXYGUANOSINE; DNA DAMAGE; FEMALE; FREE RADICALS; HUMANS; MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; STATUS EPILEPTICUS; TEMPORAL LOBE; THEOPHYLLINE; TREATMENT OUTCOME; UP-REGULATION;

EID: 33750527305     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.07.002     Document Type: Article

References (24)

1. Sagduyu A., Tarlaci S., and Sirin H. Generalized tonic-clonic status epilepticus: causes, treatment, complications and predictors of case fatality. J Neurol 245 (1998) 640-646
2. Sahin M., Menache C.C., Holmes G.L., and Riviello J.J. Outcome of severe refractory status epilepticus in children. Epilepsia 42 (2001) 1461-1467
3. Baxter P., Clarke A., Cross H., Harding B., Hicks E., Livingston J., et al. Idiopathic catastrophic epileptic encephalopathy presenting with acute onset intractable status. Seizure 12 (2003) 379-387
4. Cooke M.S., Evans M.D., Dizdaroglu M., and Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17 (2003) 1195-1214
5. Sato S., Mizuno Y., and Hattori N. Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease. Neurology 64 (2005) 1081-1083
6. Hata I., Kaji M., Hirano S., Shigematsu Y., Tsukahara H., and Mayumi M. Urinary oxidative stress markers in young patients with type 1 diabetes. Pediatr Int 48 (2006) 58-61
7. Kimura S., Yamauchi H., Hibino Y., Iwamoto M., Sera K., and Ogino K. Evaluation of urinary 8-hydroxydeoxyguanine in healthy Japanese people. Basic Clin Pharmacol Toxicol 98 (2006) 496-502
8. Calabrese V., Lodi R., Tonon C., D'Agata V., Sapienza M., Scapagnini G., et al. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J Neurol Sci 233 (2005) 145-162
9. Lan J., Henshall D.C., Simon R.P., and Chen J. Formation of the base modification 8-hydroxyl-2′-deoxyguanosine and DNA fragmentation following seizures induced by systemic kainic acid in the rat. J Neurochem 74 (2000) 302-309
10. Sener R.N. Lesions affecting the claustrum. Comput Med Imaging Graph 22 (1998) 57-61
11. Guirado S., Real M.A., Olmos J.L., and Davila J.C. Distinct types of nitric oxide-producing neurons in the developing and adult mouse claustrum. J Comp Neurol 465 (2003) 431-444
12. Gupta R.C., and Dettbarn W.D. Prevention of kainic acid seizures-induced changes in levels of nitric oxide and high-energy phosphates by 7-nitroindazole in rat brain regions. Brain Res 981 (2003) 184-192
13. Lin R., Liao C., and Lin Y. Replication-incompetent virions of Japanese encephalitis virus trigger neuronal cell death by oxidative stress in a culture system. J Gen Virol 85 (2004) 521-533
14. Wallace D.C. Mitochondrial diseases in man and mouse. Science 283 (1999) 1482-1488
15. Oliver C.N., Starke-Reed P.E., Stadtman E.R., Liu G.J., Carney J.M., and Floyd RA. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc Natl Acad Sci U S A 87 (1990) 5144-5147
16. Watt N.T., and Hooper NM. The response of neurones and glial cells to elevated copper. Brain Res Bull 55 (2001) 219-224
17. Tchekalarova J., Kambourova T., and Georgiev V. Long-term theophylline treatment changes the effects of angiotensin II and adenosinergic agents on the seizure threshold. Brain Res Bull 52 (2000) 13-16
18. Delanty N., French J.A., Labar D.R., Pedley T.A., and Rowan A.J. Status epilepticus arising de novo in hospitalized patients: an analysis of 41 patients. Seizure 10 (2001) 116-119
19. Gulati K., Ray A., Pal G., and Vijayan V.K. Possible role of free radicals in theophylline-induced seizures in mice. Pharmacol Biochem Behav 82 (2005) 241-245
20. Schulpis K.H., Lazaropoulou C., Regoutas S., Karikas G.A., Margeli A., Tsakiris S., et al. Valproic acid monotherapy induces DNA oxidative damage. Toxicology 217 (2006) 228-232
21. Komatsu M., Hiramatsu M., and Willmore L.J. Zonisamide reduces the increase in 8-hydroxy-2′-deoxyguanosine levels formed during iron-induced epileptogenesis in the brains of rats. Epilepsia 41 (2000) 1091-1094
22. Tsuchiya M., Asada A., Maeda K., Ueda Y., Sato E.F., Shindo M., et al. Propofol versus midazolam regarding their antioxidant activities. Am J Respir Crit Care Med 163 (2001) 26-31
23. Wilson J.X., and Gelb A.W. Free radicals, antioxidants, and neurologic injury: possible relationship to cerebral protection by anesthetics. J Neurosurg Anesthesiol 14 (2002) 66-79
24. Delogu G., Antonucci A., Moretti S., Marandola M., Tellan G., Signore M., et al. Oxidative stress and mitochondrial glutathione in human lymphocytes exposed to clinically relevant anesthetic drug concentrations. J Clin Anesth 16 (2004) 189-194